Application 212945
- Type
- ANDA
- Sponsor
- AMNEAL EU LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VASOPRESSIN | VASOPRESSIN | INJECTABLE;INJECTION | 200UNITS/10ML(20UNITS/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vasostrict | VASOPRESSIN | Medical Purchasin Solutions, LLC | 6672a5c9-bcfd-d7fc-e053-2991aa0aef88 | 2023-06-01 | Warnings, Adverse reactions | VASOPRESSIN |
| Vasostrict | VASOPRESSIN | Medical Purchasing Solutions, LLC | d162d386-105d-e916-e053-2995a90a350c | 2023-05-03 | Warnings, Adverse reactions | VASOPRESSIN |
| Vasopressin | VASOPRESSIN | Amphastar Pharmaceuticals, Inc. | 4e6c737d-65e8-4af4-b301-69a93affbc7f | 2022-08-22 | Warnings, Adverse reactions | Vasopressin VASOPRESSIN |
| VASOPRESSIN | VASOPRESSIN | HF Acquisition Co LLC, DBA HealthFirst | 7ae1c8c9-7d75-55a8-e053-2991aa0af05b | 2021-11-01 | Warnings, Adverse reactions | VASOPRESSIN VASOPRESSIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72044 | ORIG | 2022-09-08 |